Medicare Will Pick Drugs For Negotiation Based On Gross Sales, Disadvantaging Highly-Rebated Products

 
• By Cathy Kelly
Rebates Won't Protect Costly Drugs From 'Negotiated' Price Cuts • Source: Shutterstock

More from Market Access

More from Pink Sheet